International Conference on Brain Disorders and Therapeutics
Stanford University, USA
Mehrdad Shamloo has completed his PhD from University of Lund, Sweden. Since the inception of his doctoral studies in 1999, he has been working in the field of neuropharmacology and drug discovery and has led numerous industrial and NIH funded research projects in this field. Currently, he is Associate Professor of Neurosurgery and director of Behavioral and Functional Neuroscience Laboratory at Stanford University School of Medicine. He directs multiple preclinical and pharmacological drug discovery program with special focus on neuroprotective compounds, cognitive enhancers, and regenerative small molecules.
Abstract : Targeting ß1-Adrenergic receptor as a novel therapeutic approach for treatment of Alzheimer’s disease
Notice: Undefined index: tittle in /var/www/universal_code/speaker-details.php on line 312